Ads
-
Related paper
- No Evidence of Disease Activity after Five Years of Autologous Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Detailed Report of Five Patients
- AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SUB-TERMINAL LIVER DISEASE PATIENTS
- Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group
- Positive Correlation between Very Small Embryonic Stem Cell, Hematopoietic Stem Cell, and Endothelial Progenitor Cell in Umbilical Cord Blood Unit
- In Vitro Activity of Ceftazidime-Avibactam against 3rd Generation Cephalosporin and Carbapenem Resistant Gram-Negative Bacteria Obtained from Blood and Fecal Samples of Hematopoietic Stem Cell Transplanted Patients
- TEN YEARS FOLLOW UP OF MULTIPLE SCLEROSIS WITH PHYSIOTHERAPY – EVIDENCE BASED STUDY
- Long-Term Rather than Short-Term Survival Benefit in Mantle Cell Lymphoma Patients Treated With Intensive ChemoImmunotherapy and Hematopoietic Stem Cell Transplantation in Real World Experience
- Rhabdomyosarcoma after Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: A Case report |Biomedgrid
- Restoring Humoral Immunity after Autologous Stem Cell Transplantation in Multiple Myeloma and Response to Post-transplantation Vaccination |Biomedgrid
- Sapovirus-Associated Severe, Prolonged Diarrhoea in an Autologous Stem-Cell Transplant Patient: Case Report and Literature Review